[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EA201270315A1 - Новые формы полициклического соединения - Google Patents

Новые формы полициклического соединения

Info

Publication number
EA201270315A1
EA201270315A1 EA201270315A EA201270315A EA201270315A1 EA 201270315 A1 EA201270315 A1 EA 201270315A1 EA 201270315 A EA201270315 A EA 201270315A EA 201270315 A EA201270315 A EA 201270315A EA 201270315 A1 EA201270315 A1 EA 201270315A1
Authority
EA
Eurasian Patent Office
Prior art keywords
new forms
polycyclic
connection
polycyclic connection
methods
Prior art date
Application number
EA201270315A
Other languages
English (en)
Other versions
EA020756B1 (ru
Inventor
Стефен Бирлмэйер
Майкл Кристи
Лоран Курвуазье
Р. Скотт Филд
Р. Кертис Холтиванджер
Линли Хи
Мартин Дж. Джейкобс
Майкл Кресс
Роберт Э. Маккин
Дейл Р. Маури
Джозеф Петрейтис
Мехран Язданиан
Original Assignee
Сефалон, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43033463&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201270315(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Сефалон, Инк. filed Critical Сефалон, Инк.
Publication of EA201270315A1 publication Critical patent/EA201270315A1/ru
Publication of EA020756B1 publication Critical patent/EA020756B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

Альтернативные формы соединения I, воспроизводимые способы их получения и способы лечения пациентов с их применением.
EA201270315A 2009-08-26 2010-08-25 Новые формы полициклического соединения EA020756B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23718009P 2009-08-26 2009-08-26
PCT/US2010/046671 WO2011028580A1 (en) 2009-08-26 2010-08-25 Novel forms of a multicyclic compound

Publications (2)

Publication Number Publication Date
EA201270315A1 true EA201270315A1 (ru) 2012-08-30
EA020756B1 EA020756B1 (ru) 2015-01-30

Family

ID=43033463

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201270315A EA020756B1 (ru) 2009-08-26 2010-08-25 Новые формы полициклического соединения

Country Status (20)

Country Link
US (1) US8633314B2 (ru)
EP (1) EP2470540B1 (ru)
JP (3) JP2013503173A (ru)
KR (1) KR20120092100A (ru)
CN (1) CN102482282A (ru)
AU (1) AU2010289746B2 (ru)
BR (1) BR112012004053A2 (ru)
CA (1) CA2772328C (ru)
CL (1) CL2012000478A1 (ru)
DK (1) DK2470540T3 (ru)
EA (1) EA020756B1 (ru)
ES (1) ES2572652T3 (ru)
HK (1) HK1171750A1 (ru)
IL (1) IL218132B (ru)
MX (1) MX2012002456A (ru)
MY (1) MY156873A (ru)
NZ (1) NZ598883A (ru)
SG (1) SG178852A1 (ru)
UA (1) UA110604C2 (ru)
WO (1) WO2011028580A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2772328C (en) * 2009-08-26 2017-06-20 Cephalon, Inc. Novel forms of a multicyclic compound
CN107207511A (zh) * 2014-11-26 2017-09-26 赛福伦公司 Parp抑制剂的结晶形式
KR20200014736A (ko) 2017-03-27 2020-02-11 테사로, 인코포레이티드 니라파립 조성물
BR112020006039A2 (pt) 2017-09-26 2020-10-06 Tesaro, Inc. formulações de niraparibe
CN109632555B (zh) * 2018-12-28 2021-07-27 上海新黄河制药有限公司 一种富马酸福莫特罗无定型含量的动态蒸汽吸附分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060276497A1 (en) * 2000-05-09 2006-12-07 Cephalon, Inc. Novel multicyclic compounds and the use thereof
US7122679B2 (en) * 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
WO2007025009A2 (en) * 2005-08-24 2007-03-01 Inotek Pharmaceuticals Corporation Indenoisoquinolinone analogs and methods of use thereof
AU2007321987B2 (en) 2006-11-20 2014-01-23 Cephalon, Inc. Method of radio-sensitizing tumors using a radio-sensitizing agent
CA2772328C (en) * 2009-08-26 2017-06-20 Cephalon, Inc. Novel forms of a multicyclic compound

Also Published As

Publication number Publication date
DK2470540T3 (en) 2016-08-01
IL218132A0 (en) 2012-06-28
CA2772328A1 (en) 2011-03-10
KR20120092100A (ko) 2012-08-20
CL2012000478A1 (es) 2012-11-05
ES2572652T3 (es) 2016-06-01
NZ598883A (en) 2014-09-26
IL218132B (en) 2018-02-28
US20120214998A1 (en) 2012-08-23
WO2011028580A1 (en) 2011-03-10
EP2470540B1 (en) 2016-04-20
CN102482282A (zh) 2012-05-30
AU2010289746A1 (en) 2012-04-12
EP2470540A1 (en) 2012-07-04
MY156873A (en) 2016-04-15
JP2016014029A (ja) 2016-01-28
US8633314B2 (en) 2014-01-21
SG178852A1 (en) 2012-04-27
BR112012004053A2 (pt) 2020-12-08
EA020756B1 (ru) 2015-01-30
HK1171750A1 (zh) 2013-04-05
JP2018035158A (ja) 2018-03-08
CA2772328C (en) 2017-06-20
AU2010289746B2 (en) 2016-07-07
UA110604C2 (uk) 2016-01-25
JP2013503173A (ja) 2013-01-31
MX2012002456A (es) 2012-05-08

Similar Documents

Publication Publication Date Title
EA201390929A1 (ru) Антитела к pcsk9 и способы их применения
EA201270149A1 (ru) Ингибиторы bace
EA201101182A1 (ru) Новые аминоазагетероциклические карбоксамиды
UY34350A (es) Derivados de pirazolquinolinona, su preparación y su uso terapéutico.
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
CL2011003229A1 (es) Compuestos conjugados derivados de criptoficina; procedimiento de preparacion; y su uso para el tratamiento del cancer.
CY1118187T1 (el) Χημικες ενωσεις
EA201270722A1 (ru) Формы рифаксимина и их применение
EA201171367A1 (ru) Винилиндазолильные соединения
EA201201357A1 (ru) Антитела к cd40
EA201491224A1 (ru) Анти-псф-тау-антитела и их применение
EA201790309A1 (ru) Антитела к fap, способы их получения и применения
CL2012003385A1 (es) Tratamiento para la incontinencia.
UY34342A (es) ?derivados de pirrolopirimidina y purina?.
EA201270254A1 (ru) Производные 5-фторпиримидинона
EA201300610A1 (ru) Хиназолинкарбоксамидазетидины
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
EA201491617A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201200218A1 (ru) Новые бициклические соединения мочевины
BR112013014119A8 (pt) Novos moduladores e métodos de uso
BR112013005116A2 (pt) moduladores e métodos de uso
EA201290880A1 (ru) Новые соединения - ингибиторы фермента
EA201490778A1 (ru) АНТИТЕЛА ПРОТИВ HtrA1 И СПОСОБЫ ПРИМЕНЕНИЯ
EA201370018A1 (ru) Составы рифаксимина и их применение
EA201200247A1 (ru) Новые азагетероциклические соединения

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ BY KZ KG MD TJ TM RU